Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4155
Abstract: To investigate the frailty status in Chinese cancer patients through establishing a novel prediction algorithm.
read more here.
Keywords:
algorithm;
chinese cancer;
frailty;
cancer ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2020 at "Journal of infection and public health"
DOI: 10.1016/j.jiph.2020.03.003
Abstract: BACKGROUND Both hospital-acquired infection (HAI) and cancer represents major health concerns worldwide, but there is a paucity of data describing HAI in Chinese cancer patients. The objective of this study is to demonstrate the prevalence,…
read more here.
Keywords:
acquired infections;
prevalence;
hospital;
chinese cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2021.05.008
Abstract: Gefitinib, a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, is used to treat non-small-cell lung cancer (NSCLC). Lung cancer rates are high in China and are expected to increase over the…
read more here.
Keywords:
pharmacokinetics gefitinib;
cancer population;
chinese cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Nursing Research"
DOI: 10.1097/nnr.0000000000000615
Abstract: Background Irritability is a common experience of depressed Chinese patients but is understudied and poorly measured. Objective We aimed to assess psychometric properties of a new measure of irritability in Chinese cancer patients across the…
read more here.
Keywords:
chinese cancer;
cancer patients;
version;
irritability scale ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-065075
Abstract: Introduction Fear of cancer recurrence (FCR) is a prevalent and frequently debilitating response to a cancer diagnosis, affecting a substantial proportion of cancer survivors. Approximately 30% of local Hong Kong Chinese cancer survivors in a…
read more here.
Keywords:
cancer recurrence;
fear cancer;
chinese cancer;
intervention ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.898916
Abstract: BRCA1/2 mutation is a biomarker for guiding multiple solid tumor treatment. However, the prevalence of BRCA1/2 large genomic rearrangements (LGRs) in Chinese cancer patients has not been well revealed partially due to technical difficulties in…
read more here.
Keywords:
brca1;
lgr;
brca2;
cancer patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.803543
Abstract: Background Fear of cancer recurrence (FCR) is a significant issue for most cancer patients. Until now, a detailed investigation of the structure of FCR and the interaction among its constituent elements is lacking. This study…
read more here.
Keywords:
fcr;
network;
cancer patients;
chinese cancer ... See more keywords